ATE67992T1 - In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften. - Google Patents
In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften.Info
- Publication number
- ATE67992T1 ATE67992T1 AT87306002T AT87306002T ATE67992T1 AT E67992 T1 ATE67992 T1 AT E67992T1 AT 87306002 T AT87306002 T AT 87306002T AT 87306002 T AT87306002 T AT 87306002T AT E67992 T1 ATE67992 T1 AT E67992T1
- Authority
- AT
- Austria
- Prior art keywords
- substituted
- cardiotnic
- compounds
- position nitrogen
- iii effect
- Prior art date
Links
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 title abstract 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- -1 NITROGEN-SUBSTITUTED ISOQUINOLINOL COMPOUNDS Chemical class 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000024883 vasodilation Effects 0.000 title 1
- GYPOFOQUZZUVQL-UHFFFAOYSA-N 2h-isoquinolin-3-one Chemical class C1=CC=C2C=NC(O)=CC2=C1 GYPOFOQUZZUVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000003177 cardiotonic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 230000000304 vasodilatating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Lubricants (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/882,655 US4714705A (en) | 1986-07-07 | 1986-07-07 | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties |
| EP87306002A EP0252721B1 (de) | 1986-07-07 | 1987-07-07 | In 4-Stellung durch Stickstoff substituierte Isochinolinolverbindungen mit cardiotonischen, die Wirkung von Phosphodiesterase-Fraktion-III inhibierenden und/oder renal vasodilatierenden Eigenschaften |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE67992T1 true ATE67992T1 (de) | 1991-10-15 |
Family
ID=25381064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87306002T ATE67992T1 (de) | 1986-07-07 | 1987-07-07 | In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4714705A (de) |
| EP (1) | EP0252721B1 (de) |
| JP (1) | JPS6322562A (de) |
| KR (1) | KR880001603A (de) |
| CN (1) | CN87105724A (de) |
| AT (1) | ATE67992T1 (de) |
| AU (1) | AU597083B2 (de) |
| DE (1) | DE3773438D1 (de) |
| DK (1) | DK348087A (de) |
| ES (1) | ES2040750T3 (de) |
| FI (1) | FI872980A (de) |
| GR (1) | GR3002829T3 (de) |
| HK (1) | HK107591A (de) |
| HU (1) | HU196966B (de) |
| IL (1) | IL83088A (de) |
| MY (1) | MY101961A (de) |
| NO (1) | NO872812L (de) |
| NZ (1) | NZ220967A (de) |
| PH (1) | PH22571A (de) |
| PT (1) | PT85271B (de) |
| SG (1) | SG95491G (de) |
| ZA (1) | ZA874894B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880817A (en) * | 1987-06-09 | 1989-11-14 | Ortho Pharmaceutical Corporation | O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties |
| US6331543B1 (en) | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| CA2270118A1 (en) * | 1996-11-01 | 1998-05-14 | Nitromed Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1424348A (en) * | 1972-11-30 | 1976-02-11 | Wyeth John & Brother Ltd | Isoquinoline derivatives |
| JPS625963A (ja) * | 1985-07-02 | 1987-01-12 | Mitsui Toatsu Chem Inc | イソキノリン誘導体 |
-
1986
- 1986-07-07 US US06/882,655 patent/US4714705A/en not_active Expired - Lifetime
-
1987
- 1987-07-06 PH PH35498A patent/PH22571A/en unknown
- 1987-07-06 DK DK348087A patent/DK348087A/da not_active Application Discontinuation
- 1987-07-06 FI FI872980A patent/FI872980A/fi not_active Application Discontinuation
- 1987-07-06 IL IL83088A patent/IL83088A/xx unknown
- 1987-07-06 ZA ZA874894A patent/ZA874894B/xx unknown
- 1987-07-06 NZ NZ220967A patent/NZ220967A/xx unknown
- 1987-07-06 NO NO872812A patent/NO872812L/no unknown
- 1987-07-06 AU AU75273/87A patent/AU597083B2/en not_active Ceased
- 1987-07-07 JP JP62167955A patent/JPS6322562A/ja active Pending
- 1987-07-07 PT PT85271A patent/PT85271B/pt not_active IP Right Cessation
- 1987-07-07 AT AT87306002T patent/ATE67992T1/de not_active IP Right Cessation
- 1987-07-07 CN CN198787105724A patent/CN87105724A/zh active Pending
- 1987-07-07 ES ES198787306002T patent/ES2040750T3/es not_active Expired - Lifetime
- 1987-07-07 KR KR1019870007232A patent/KR880001603A/ko not_active Application Discontinuation
- 1987-07-07 HU HU873058A patent/HU196966B/hu unknown
- 1987-07-07 DE DE8787306002T patent/DE3773438D1/de not_active Expired - Lifetime
- 1987-07-07 EP EP87306002A patent/EP0252721B1/de not_active Expired - Lifetime
- 1987-07-14 MY MYPI87001002A patent/MY101961A/en unknown
-
1991
- 1991-10-03 GR GR91401380T patent/GR3002829T3/el unknown
- 1991-11-08 SG SG954/91A patent/SG95491G/en unknown
- 1991-12-23 HK HK1075/91A patent/HK107591A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7527387A (en) | 1988-01-14 |
| NO872812D0 (no) | 1987-07-06 |
| PT85271B (pt) | 1990-03-30 |
| EP0252721A1 (de) | 1988-01-13 |
| IL83088A (en) | 1991-08-16 |
| CN87105724A (zh) | 1988-03-09 |
| ZA874894B (en) | 1989-02-22 |
| EP0252721B1 (de) | 1991-10-02 |
| PH22571A (en) | 1988-10-17 |
| HK107591A (en) | 1992-01-03 |
| MY101961A (en) | 1992-02-29 |
| PT85271A (en) | 1987-08-01 |
| AU597083B2 (en) | 1990-05-24 |
| DK348087A (da) | 1988-01-08 |
| SG95491G (en) | 1991-12-13 |
| HUT44515A (en) | 1988-03-28 |
| ES2040750T3 (es) | 1993-11-01 |
| US4714705A (en) | 1987-12-22 |
| FI872980A0 (fi) | 1987-07-06 |
| GR3002829T3 (en) | 1993-01-25 |
| NO872812L (no) | 1988-01-08 |
| IL83088A0 (en) | 1987-12-31 |
| NZ220967A (en) | 1990-07-26 |
| FI872980A (fi) | 1988-01-08 |
| HU196966B (en) | 1989-02-28 |
| KR880001603A (ko) | 1988-04-25 |
| DE3773438D1 (de) | 1991-11-07 |
| DK348087D0 (da) | 1987-07-06 |
| JPS6322562A (ja) | 1988-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3788057T2 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
| DE69205881D1 (de) | Behandlung von Sinterlegierungen. | |
| ATE67992T1 (de) | In 4-stellung durch stickstoff substituierte isochinolinolverbindungen mit cardiotonischen, die wirkung von phosphodiesterase-fraktion-iii inhibierenden und/oder renal vasodilatierenden eigenschaften. | |
| ES2038668T3 (es) | Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica. | |
| DE3765808D1 (de) | Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe. | |
| ATE83481T1 (de) | Fuenfgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen. | |
| DE3765485D1 (de) | Herstellung von metallgluconaten. | |
| ATE66921T1 (de) | Verwendung von triazolylderivate zur bekaempfung von pilzen. | |
| ATE85331T1 (de) | Azolverbindungen. | |
| CA1262906C (en) | 3-(2-FUROYL)-5-ALCOXYCARBONYL-2,6-DIMETHYL-4-(2-NITROPHENYL)-1,4-DIHYDROPYRIDINES, CALCIUM ANTAGONISTS | |
| DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen | |
| DE3586321D1 (de) | Verwendung von 1,4-dihydropyridinderivaten. | |
| FI871737A0 (fi) | Kraftanlaeggning med foerbraenning i en fluidiserad baedd. | |
| DE68915143D1 (de) | Die Verwendung von Azol-Beschleunigern in anaeroben Zusammensetzungen. | |
| ATE64683T1 (de) | Zusammensetzung zur behandlung von haemorroiden. | |
| ATE102035T1 (de) | Verwendung von 5-heteroaryl- oder 5arylsubstituierten imidazo(2,1-a)isochinolinen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |